FDA pushes forward on gene-editing therapies with new safety roadmap
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Move strengthens footprint in Western India and expands multi-specialty care network
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The company allocated €56 million to research and development for next-generation line solutions
Subscribe To Our Newsletter & Stay Updated